United States Biotechnology & Medical Research

Kaleido Biosciences Inc (KLDO)

Track

Track

Ticker: KLDO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Menichella Daniel L Chief Executive Officer Executive Director
Transaction date
Purchase
Price
334.49
Quantity 99,485 +3.3%
Value US$1,592,658
2.4
MELAS KYRIAZI THEO Non-Executive Director
Transaction date
Purchase
Price
7.50
Quantity 33,333 +inf%
Value US$249,998
3.0
BONNEY MICHAEL W Executive Chair Executive Director
Transaction date
Purchase
Price
14.65
Quantity 2,555 +0.3%
Value US$37,431
3.0
BONNEY MICHAEL W Executive Chair Executive Director
Transaction date
Purchase
Price
13.95
Quantity 68,965 +7.4%
Value US$962,062
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-02-26 2021-02-08 B Purchase
Menichella Daniel L

Chief Executive Officer

Executive Director
99,485 +3.3%
334.49
US$1,592,658 		99,485 +3.3% 334.49 US$1,592,658
2021-02-10 2021-02-08 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
7,727 +46.2%
397.67
US$3,333,957 		7,727 +46.2% 397.67 US$3,333,957
2021-02-10 2021-02-08 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
21,268 -28.6%
20.01
US$1,189,234 		21,268 -28.6% 20.01 US$1,189,234
2021-02-10 2021-02-08 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
71,666 +4.4%
11.50
US$824,159 		71,666 +4.4% 11.50 US$824,159
2020-06-08 2020-06-04 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
666,666 +inf%
7.50
US$4,999,995 		666,666 +inf% 7.50 US$4,999,995
2020-06-08 2020-06-04 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
666,667 +29.7%
7.50
US$5,000,002 		666,667 +29.7% 7.50 US$5,000,002
2020-06-08 2020-06-04 B Purchase
3.0
Flagship Ventures Fund IV General Partner LLC
Large shareholder
666,667 +70.4%
7.50
US$5,000,002 		666,667 +70.4% 7.50 US$5,000,002
2020-06-05 2020-06-04 B Purchase
2.4
MELAS KYRIAZI THEO
Non-Executive Director
33,333 +inf%
7.50
US$249,998 		33,333 +inf% 7.50 US$249,998
2019-03-06 2019-03-04 B Purchase
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
333,333 +17.4%
15.00
US$4,999,995 		333,333 +17.4% 15.00 US$4,999,995
2019-03-06 2019-03-04 B Purchase
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
333,333 +5.4%
15.00
US$4,999,995 		333,333 +5.4% 15.00 US$4,999,995
2019-03-06 2019-03-04 B Purchase
3.9
Flagship Ventures Fund V General Partner LLC
Large shareholder
266,667 +11.6%
15.00
US$4,000,005 		266,667 +11.6% 15.00 US$4,000,005
2019-03-04 2019-02-28 B Purchase
3.0
BONNEY MICHAEL W

Executive Chair

Executive Director
2,555 +0.3%
14.65
US$37,431 		2,555 +0.3% 14.65 US$37,431
2019-03-04 2019-02-28 B Purchase
3.0
BONNEY MICHAEL W

Executive Chair

Executive Director
68,965 +7.4%
13.95
US$962,062 		68,965 +7.4% 13.95 US$962,062
Explore more

More insider trading research around Kaleido Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America